Industry Presentations

Transthyretin Amyloid Cardiomyopathy (ATTR-CM)


Presentations


Speakers

  • Nitasha Sarswat, MD

    Nitasha Sarswat, MD

    Nitasha Sarswat, MD

    Nitasha Sarswat, MD, is an assistant professor in the Section of Cardiology of the Division of Advanced Heart Failure and Transplantation at the University of Chicago in Chicago, Illinois, and director of the Cardiac Amyloidosis Program at The University of Chicago Medicine. Dr Sarswat received her medical degree from Northwestern University Feinberg School of Medicine in Chicago. She completed her internal medicine residency at New York University Hospitals in New York, New York, and served as a postdoctoral research fellow in advanced heart failure and transplantation at Albert Einstein College of Medicine/Montefiore Medical Center in Bronx, New York; fellow in cardiovascular disease at UMDNJ Hospitals in Camden, New Jersey; and fellow in advanced heart failure and transplantation at Massachusetts General Hospital in Boston, MA.

    Dr Sarswat is a member of such organizations as the American Heart Association, American College of Cardiology, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, and International Society for Heart and Lung Transplantation.

    Dr Sarswat has authored or co-authored dozens of peer-reviewed articles on advanced heart failure, mechanical circulatory support, and transplantation. She serves as a principal investigator for clinical trials and has given presentations at facilities and professional society meetings locally and nationally. Her clinical interests include cardiac amyloidosis, cardiac sarcoidosis, and hemodynamics.
  • Jignesh Patel, MD, PhD, FACC, FRCP, FAST

    Jignesh Patel, MD, PhD, FACC, FRCP, FAST

    Jignesh Patel, MD, PhD, FACC, FRCP, FAST

    Jignesh Patel, MD, PhD is the Medical Director of the Heart Transplant Program and Director of the Cardiac Amyloid Program at Cedars-Sinai Heart Institute. He earned his bachelor’s degree with honors and medical degree at the University of Cambridge. He earned his doctorate in vascular biology and physiology at UCLA. After becoming a member of the Royal College of Physicians (MRCP) in the United Kingdom, Dr. Patel pursued internal medicine residency at the Cleveland Clinic Foundation. He subsequently completed training in cardiovascular diseases in conjunction with his doctorate in the Subspecialty Training and Advanced Research (STAR) Program at UCLA, where he also served as a clinical instructor and chief cardiology fellow. He is board certified in cardiovascular disease and in heart failure and transplant cardiology and trained in nuclear cardiology. He has had a longstanding interest in all aspects of cardiovascular disease with special expertise in the management of patients with advanced heart failure and following cardiac transplantation. Dr. Patel has been the principal investigator or co-investigator of more than 75 research projects in areas related to heart failure and cardiac transplantation, including clinical trials of novel immunosuppressive agents, non-invasive technologies for the detection of rejection and multi-center trials of device therapy in congestive heart failure. His research into these and other areas has resulted in more than 100 articles in peer reviewed publications, several books chapters and more than 400 abstracts. He is a reviewer for several journals. He also has lectured extensively around the world on heart failure, transplantation and immunosuppression.
  • Prem Soman, MD

    Prem Soman, MD

    Prem Soman, MD

    Prem Soman is a tenured Associate Professor of Medicine and Clinical & Translational Science at the University of Pittsburgh, and director of Nuclear Cardiology, the Advanced Cardiac Imaging Fellowship and the newly established Multidisciplinary Cardiac Amyloidosis Center at the University of Pittsburgh Medical Center (UPMC).

    After initial medical training in India, he was a clinical research fellow at the Northwick Park Hospital and Institute of Medical Research at Harrow, London, UK, where he obtained a PhD. His Cardiology and Advanced Imaging Fellowships in the US were at Tufts Medical Center, Boston, after which he joined the faculty at UPMC.

    He was the President of the American Society of Nuclear Cardiology in 2018, and previously, Chair of the Imaging Council of the ACC, and President of the CV Council of the Society of Nuclear Medicine and Molecular Imaging. He is currently Associate Editor of Circulation CV Imaging, and prior Associate Editor of the Journal of Nuclear Cardiology. Dr. Soman has co-authored numerous original research papers, guidelines, reviews, and text book chapters. His areas of research interest apart from cardiac amyloidosis focus on the use of radionuclide imaging in heart diseases.
  • Frederick Ruberg, MD

    Frederick Ruberg, MD

    Frederick Ruberg, MD

    Associate Professor of Medicine and Radiology

    Frederick Ruberg, MD, is an associate professor of medicine and radiology in the Chapter of Cardiovascular Medicine at Boston University (BU) School of Medicine and a clinical cardiologist at Boston Medical Center (BMC) in Boston, Massachusetts, specializing in cardiac imaging and infiltrative heart disease. Dr Ruberg has an active clinical practice as the senior cardiologist at the BU Amyloidosis Center. In addition, he is associate chief of cardiovascular medicine for academic affairs, co-director of the Cardiovascular Medicine Fellowship Program, and director of the Cardiac MRI Program at BMC, and of the Integrated Pilot Grants Program at the BU Clinical & Translational Science Institute.

    Dr Ruberg received his medical degree from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, Pennsylvania, and completed his internal-medicine residency at Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts. Dr Ruberg completed his fellowship in cardiovascular disease at BMC, BU School of Medicine, and in cardiovascular magnetic resonance imaging at Beth Israel Deaconess Medical Center, Harvard Medical School.

    Dr Ruberg serves as an associate editor of Circulation: Cardiovascular Imaging and is a fellow of the American Heart Association. His National Institutes of Health–funded research program focuses on the application of noninvasive cardiac imaging for amyloidosis identification and clinical care optimization. In addition, Dr Ruberg’s area of research interest is amyloid transthyretin (ATTR) amyloidosis and, in particular, the inherited form of the disease (hATTR or ATTRm). Current projects involve the application of pyrophosphate imaging for detection of ATTR amyloidosis, application of echocardiographic strain imaging as a disease marker, and validation of point-of-care diagnostic tools for cardiac amyloidosis identification in the outpatient clinic. Dr Ruberg is committed to raising awareness of cardiac amyloidosis.
  • Jamieson Bourque, MD, MHS

    Jamieson Bourque, MD, MHS

    Jamieson Bourque, MD, MHS

    Associate Professor of Medicine and Radiology

    Jamieson Bourque, MD, MHS, is an associate professor of medicine and radiology at the University of Virginia (UVA) Health System in Charlottesville, Virginia, where he is medical director of nuclear cardiology and the stress laboratory. He also serves as medical director of cardiology at Novant Health UVA Health System Culpeper Medical Center in Culpeper, Virginia. He completed medical school and his residency at Duke University School of Medicine in Durham, North Carolina, and his cardiology and advanced multimodality cardiovascular imaging fellowships at UVA, joining the faculty in 2010.

    Dr Bourque is a fellow of the American Society of Nuclear Cardiology and American College of Cardiology, as well as a member of the American Heart Association, Society for Cardiovascular Magnetic Resonance, and Society of Nuclear Medicine and Molecular Imaging.

    Dr Bourque has overseen the creation and expansion of the UVA cardiac positron emission tomography program and supervises the stress testing and nuclear cardiology training of the UVA cardiovascular fellows. He has an active research program, focusing on the identification and treatment of coronary microvascular disease and risk stratification in ischemic heart disease. He is currently serving as co-chair of a group developing a multisociety consensus statement on multimodality imaging in cardiac amyloidosis.